Miles J. Stoner, @StockHollywood

Dallas, Texas


July 27

~ Milestone Financial Investments LLC - Intra-Day Scalping at its Finest ~
"If I told you I was a scalping man, you'd agree."
  • US Stocks Climb, Lifting DJIA Into Black For Year 
    • Back into the black this year, what month is is? Damn, only 7 months into it and we are even. We got to be doing something terribly terribly _____. (you fill in the blank)
  • Nasdaq-100 After-Hours Indicator Down 0.75 at 1,889.65  
    •  Barely down, but I expect us to start pushing on this level and bringing it down some I longed FAZ after hours just in case we open lower.
  • BP set to replace CEO; spill cleanup resumes
    •  Friday Congress votes on ending a cap on damage payment, could be Death for BP.
  • Fed's Yellen Warns Against Raising Inflation Target  
    •  Inflation is good, deflation is bad and with Bernake saying we're ready to stimulate if so needed has me thinking they have "an invention called a printing press," duh. We in trouble.
  • US home sales surge in June, inventory at 42-yr low 
    • Why did they surge? Well tax credit was one reason why, so its down hill from here. Interesting fact want to know the worst month for auto sales since 2008, mmmmmmmmm, June!
  1. Onyx Pharmaceuticals Inc (ONXX:$25.00,00$3.50,0016.28%) is bounding up as it reported encouraging results for its cancer drug.
    • Onyx plans to file for FDA market approval by the end of this year.
    • Shares in the Emeryville, California-based company have traded between $19.54 and $36.59 over the past 12 months. 
    •  25.13-26.38
  2. Zoran Corp. (ZRAN:$9.77,00$-0.01,00-0.10%) slumped lower in evening trade on the back of disappointing results and guidance.
    •  9.83-8.66
  3. IDT (IDTI:$5.63, up.17c, up3.11%) gained in night trade after reporting a year-over-year increase in Q1 results and approving a stock buyback plan.
    •  5.46-5.94
  4. Veeco Instruments (VECO:$44.69,00$1.96,004.59%) advanced in after-hours trade after reporting better-than-expected results and guidance.
    •  42.73-48.01
  5. The U.S. International Trade Commission ruled Monday that graphics-chip maker Nvidia Corp. (NVDA:$10.55,00$0.19,001.83%) infringed patents held by 
    • 10.68-10.35
  6. Rambus Inc. (RMBS:$19.59,00$0.60,003.16%) and said it will issue an order that bars the importation of some Nvidia products into the U.S. ((see above profile alert)
    •  18.99-23.19
  7. Ultra Clean Holdings Inc. (UCTT:$9.45,00$0.21,002.27%) swung to a second-quarter profit as sales rose more than quadrupled and the semiconductor-industry supplier predicted record results this quarter.
    •  9.45-10.44
  8. Shares of Mindspeed Technologies (MSPD:$8.80,00$0.32,003.77%) are flat in after-hours trading after the company reported third quarter earnings that beat analysts' estimates.
    • 9.07-8.48
  9. U.S. House Democrats unveiled a bill Monday that would eliminate the cap on damage claims that BP PLC (BP:$38.65, up$1.7, up4.86%) and other oil companies would have to pay for spills such as the one in the Gulf of Mexico, setting the stage for a vote Friday on the first chamber-wide response to the worst offshore oil spill in U.S. history.
    • Basically, on friday congress will vote on eliminating a stopping point for paying for this spill!
    • Their new CEO will be American and oil cleanup in on track, hoping there are no hurricanes during hurricane season.
    • 38.7-38.4, I expect a bigger drop on Friday if that legislation passes, maybe flat before then or up or down depending on how the market takes the news and wants to speculate. Short.
  10. Shares of Volterra Semiconductor (VLTR:$27.65,00$0.65,002.41%) were down in after-hours trading after the company reported second-quarter earnings that were slightly better than analysts' estimates.
    • Beats Street's Q2 Estimates - Shares Down 7% in After Hours
    • 27.65-25.02
  11. Legg Mason Inc (LM:$30.08,00$0.99,003.40%) reported on Monday its quarterly earnings decreased more than expected as expenses rose and investors pulled money out of many of its funds.
    • 1Q Net Drops On Outflows,Investment Declines.    
    • 30.25-28.50   
  12. Sanmina-SCI Corp. (SANM:$15.86,00$0.70,004.62%) swung to a fiscal third-quarter profit on double- digit sales growth and improved margins.
    •  15.84-14, this has possibility to swing to positive territory tomorrow.
  13. Western Union (WU:$16.68,00$0.37,002.27%) is sticking close to its day highs after the company announced with Family Dollar (FDO) agreement to offer the Western Union goCASHSM service, a new U.S. in-lane money transfer service from Western Union, across 6,500 Family Dollar store locations.
    •  16.3-17
  14. Momenta Pharmaceuticals Inc (MNTA:$26.11,00$4.41,0020.32%)  
    • had been granted U.S. approval to market a generic version of Sanofi-Aventis blood thinner Lovenox.
    • Sanofi asks U.S. court to block generic blood thinner!!!
    • 26.19-21.70
  15. U.S. reviewers gave mixed views on AstraZeneca Plc's (AZN:$50.51,00$1.89,003.89%) experimental blood thinner but the company's shares rose on investor optimism that an advisory panel will back the potential blockbuster drug.
    • 49.41-50.73
  16. Genzyme Corp. (GENZ:$67.38,00$4.86,007.77%) helped lead drug stocks into positive territory Monday during a largely bullish morning for the sector on Wall Street.
    • 67.31-62.5, ended up after hours about flat where it closed at 67, but had a nice dip for possible buying opportunities tomorrow.
  17. WBB Securities analyst Stephen Brozak said given Vivus' setbacks, investors interested in the obesity-drug sector have only two choices--Arena or Orexigen.
    • Arena Pharmaceuticals (ARNA:$6.34,00$0.43,007.28%)
      • Metabolic Drugs Advisory Committee meeting on September 16 
      • 6.34-6.51
    • Orexigen Therapeutics Inc (OREX:$4.90, up.55c, up12.64%.
      • 4.72-4.94
  18.  Masco Corp (MAS:$11.93,00$0.51,004.47%) posted a better-than-expected quarterly profit but warned that second half would be challenging as home building activity was slowing and big-ticket items would continue to be deferred.
    •  2Q Profit Tumbles 95% On Charges, But Sales Grow 
    • 11.97-11.4
    • Short any pop in this stock, major sell off at open, I'm soothsaying.
  19. Specialty chemical producer Albemarle Corp (ALB:$45.25,00$1.03,002.33%) on Monday reported its quarterly profit doubled from a year earlier, as sales rose across all its segments.
    • 44.83-46.45
    • Obviously, good news, but I don't know their forecast for next Quarter.